Yunnan Baiyao Group Co Ltd
SZSE:000538

Watchlist Manager
Yunnan Baiyao Group Co Ltd Logo
Yunnan Baiyao Group Co Ltd
SZSE:000538
Watchlist
Price: 55.93 CNY 0.36% Market Closed
Market Cap: 99.8B CNY

Yunnan Baiyao Group Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Yunnan Baiyao Group Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
ÂĄ40.8B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
7%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Revenue
ÂĄ26.2B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
11%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ13.2B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ9.8B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
19%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ31B
CAGR 3-Years
13%
CAGR 5-Years
4%
CAGR 10-Years
13%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ5.8B
CAGR 3-Years
94%
CAGR 5-Years
37%
CAGR 10-Years
N/A
No Stocks Found

Yunnan Baiyao Group Co Ltd
Glance View

Market Cap
99.8B CNY
Industry
Pharmaceuticals

Yunnan Baiyao Group Co Ltd is a captivating story of fusion between traditional Chinese medicine and modern business acumen. Rooted in Yunnan province's rich heritage, the company traces its origins back to the early 1900s when a local healer discovered a potent remedy for addressing wounds and reducing bleeding. Over the years, this original formula, a tightly-kept secret, evolved into a cornerstone product that propelled Yunnan Baiyao into the spotlight. As the company expanded, it embraced an adept strategy of integrating traditional formulations with contemporary pharmaceutical practices, enabling it to carve out a niche within the global health sector. Today, Yunnan Baiyao Group boasts a diversified portfolio that extends beyond its flagship product to include various health care, personal care, and even veterinary offerings. Its revenue model intricately weaves together streams from over-the-counter remedies, prescription medications, and consumer healthcare products. The company's innovative stride into the realms of cosmetics and toothpaste indicates its agility in adapting ancient knowledge for contemporary consumer demands. Strategic marketing emphasizes the unique heritage and trusted efficacy of its products, helping Yunnan Baiyao solidify its standing in a competitive market. As it continues to grow, the group remains a compelling example of how deeply-rooted tradition can be harnessed to drive a modern enterprise to sustained profitability.

Intrinsic Value
71.21 CNY
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Yunnan Baiyao Group Co Ltd's Revenue?
Revenue
40.8B CNY

Based on the financial report for Sep 30, 2025, Yunnan Baiyao Group Co Ltd's Revenue amounts to 40.8B CNY.

What is Yunnan Baiyao Group Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Yunnan Baiyao Group Co Ltd have been 5% over the past three years , 5% over the past five years , and 7% over the past ten years .

Back to Top